Source Genomics Expands Access to Precision Oncology with Innovative Biomarker-Driven Testing Portfolio
Editor2025-10-14T13:27:16+00:00Source Genomics, a part of the Source BioScience group, announced the launch of its expanded portfolio of biomarker-driven tests, designed to enhance clinical decision-making and improve patient access to precision care. This milestone reinforces the company’s commitment to advancing oncology diagnostics and supporting clinicians in delivering tailored treatment strategies. As a trusted laboratory partner, Source Genomics [...]










